Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2011-04-07 Proxy Solicitation & In…
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Notice of General Meeting/Proxy Form 17 pages 104.3KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'Notice of General Meeting and Explanatory Statement' for Phylogica Limited, detailing the agenda and resolutions for a General Meeting scheduled on 10 May 2011. The content includes detailed descriptions of capital raising through share placements (Tranche 1 and Tranche 2), voting exclusions, proxy instructions, and explanatory notes about the purpose and effect of the capital raising. It is a formal notice sent to shareholders to inform them about the meeting and to solicit their votes on specific resolutions related to share issuance and director participation in the placements. There are no financial statements or detailed financial performance data included, nor is this a transcript or presentation. The document is not a report itself but a notice and explanatory statement for a shareholder meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2011-04-07 English
Corporate Changes 1 page 42.7KB
Board/Management Information Classification · 95% confidence The document announces changes in the company's corporate structure, specifically the resignation of the Company Secretary and appointment of a new Company Secretary, as well as a change in the Registered Office address. There is no financial data, report, or regulatory filing referenced. The content fits the category of announcements related to changes in the company's board or senior management positions. Therefore, the document is best classified as Board/Management Information (MANG). The document length is short and does not indicate it is a report or announcement of a report publication.
2011-04-04 English
Appendix 3B 1st Tranche B 8 pages 196.1KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - 1st Tranche Capital Raising (balance)' and is an 'Appendix 3B New issue announcement' which is a standard form used for announcing new securities issuance and application for quotation on the ASX (Australian Securities Exchange). It details the number and class of securities issued, issue price, purpose of the issue, and other related information about the capital raising. There are no financial statements or detailed financial performance data included, nor is it a report or presentation. The document is clearly an announcement related to capital raising and new share issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is over 10,000 characters, so it is not a mere brief announcement of a report publication (RPA).
2011-04-03 English
Appendix 3B 1st Tranche A 10 pages 206.6KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B - 1st Tranche Capital Raising (part)' and is addressed to the ASX (Australian Securities Exchange). It details the issuance of new ordinary shares and options as part of a capital raising. The document includes specifics such as the number and class of securities issued, issue price, purpose of the issue, dates of allotment, and a spread of holders of the new options. Appendix 3B is a standard form used in Australia for announcing new issues of securities and applying for quotation of those securities on the ASX. The content focuses on capital raising activities and the issuance of new shares and options, which aligns with the category of Capital/Financing Update (CAP). The document is not a full financial report, earnings release, or management discussion, nor is it a regulatory filing or announcement of voting results. It is a detailed announcement of a capital raising event and new securities issuance.
2011-03-31 English
Cleansing disclosure document 34 pages 2.4MB
Capital/Financing Update Classification · 95% confidence The document is titled 'Prospectus' and relates to an offer of shares and options by Phylogica Limited. It includes detailed information about the capital raising, share and option offers, risk factors, timetable for the offers, and legal disclaimers. The document is prepared in accordance with the Corporations Act and lodged with ASIC, indicating it is a formal offering document for new securities. This type of document is a prospectus used for capital raising and financing activities, not a report of financial results or management information. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offer information, not just an announcement or a brief summary, confirming it is not a Report Publication Announcement or Regulatory Filing. Hence, the classification is CAP with high confidence.
2011-03-29 English
Phylogica Limited Share Placement raises $5.2 million 2 pages 87.8KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 25 March 2011 from Phylogica Limited regarding a share placement to raise $5.2 million. It details the terms of the placement, including the number of shares and options issued, pricing, and the use of proceeds. There is no financial statement or detailed financial report included, only information about a capital raising event. The document length is 3668 characters, which is relatively short and consistent with an announcement rather than a full report. The content clearly fits the category of a capital or financing update rather than an annual report, earnings release, or other types of filings. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2011-03-24 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.